Last reviewed · How we verify
NCT04712786
Refractive Changes Following Vitrectomy
trial testing pars plana vitrectomy in Retinal Detachment in 47 participants. Completed in 27 December 2020.
25 December 2020
Quick facts
| Lead sponsor | Bursa Retina Eye Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 47 |
| Start date | 1 December 2020 |
| Primary completion | 25 December 2020 |
| Estimated completion | 27 December 2020 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- pars plana vitrectomy
Conditions studied
- Retinal Detachment — all drugs for Retinal Detachment →
- Refractive Errors — all drugs for Refractive Errors →
- Vitreous Hemorrhage — all drugs for Vitreous Hemorrhage →
- Epiretinal Membrane — all drugs for Epiretinal Membrane →
Sponsor
Bursa Retina Eye Hospital
Who can join
18 and older, any sex, with Retinal Detachment or Refractive Errors. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
We aimed o compare the refractive changes associated with pars plana vitrectomy with or without intraocular gas tamponade in pseudophakic eyes. This retrospective study included pseudophakic patients with Nd:YAG laser posterior capsulotomy who underwent 23G PPV between February 2015 and March 2019. Group 1 consisted of patients with regmatogenous RD who underwent PPV and 12% perflouropropane (C3F8) gas tamponade whereas Group 2 consisted of patients who underwent PPV for epiretinal membrane or vitreous hemorrhage (VH). No tamponade was used in Group 2. Minimum follow-up was 12 months.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04712786
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of pars plana vitrectomy
Trials testing the same drug.
- NCT05367193 — 3D Visualization System for Vitreoretinal Diseases in Highly Myopic Eyes · NA · completed
- NCT06233500 — Macular Micro Vascular Changes Following Macular Hole Repair : Optical Coherence Tomography Angiography Study · NA · unknown
- NCT04774146 — Quantification of Silicone Oil Emulsification After Pars Plana Vitrectomy · unknown
- NCT06133660 — Influence of Intravitreal Aqueous Tamponade on Lens Status and Ocular · completed
Other recruiting trials for Retinal Detachment
Currently open trials in the same condition.
- NCT06587945 — Nicotinamide Riboside Oral Supplementation in Macula Off Retinal Detachment · Phase 4 · recruiting
- NCT06985030 — Head Position Monitoring After Pars Planar Vitrectomy · active not recruiting
- NCT06830070 — Subjective Pain Scoring for Subtenonal Anesthesia During Vitrectomy · active not recruiting
- NCT03713268 — Intraoperative OCT Guidance of Intraocular Surgery II · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04712786 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bursa Retina Eye Hospital
- Last refreshed: 15 January 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04712786.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing